Natco Pharma makes strategic investment in ISCA Inc

31 Aug 2023 Evaluate

Natco Pharma has made strategic investment in ISCA, Inc., a Delaware Corporation, which had a turnover of $9.3 million in the last fiscal year ending in December 2022. Cost of acquisition is $2 million. The company has made strategic investment for bio control of pest.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

833.85 -6.00 (-0.71%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×